{"entity":{"type":"insider","cik":"0001351779","url":"/insider/0001351779","json_url":"/insider/0001351779.json","name":"KIDRON NADAV","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":8,"first":"2015-03-20","last":"2023-03-16","span_basis":"filed_date"},"name_variants":[{"name":"KIDRON NADAV","source":"filing","n_filings":8,"first_seen":"2015-03-20","last_seen":"2023-03-16"}],"transactions":[{"id":8606649,"accession":"0001209191-23-019367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-019367","line_url":"/filing/0001209191-23-019367#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":2.039,"price_display":"2.04","price_state":"stated","total_value":53014.0,"total_display":"53,014.00","total_whole":"53,014","shares_owned_after":126000.0,"shares_owned_after_display":"126,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-16","scope":"insider"},{"id":8071859,"accession":"0001209191-23-018956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018956","line_url":"/filing/0001209191-23-018956#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":201000.0,"total_display":"201,000.00","total_whole":"201,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":9272869,"accession":"0001213900-21-063945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-063945","line_url":"/filing/0001213900-21-063945#line-1","is_derivative":false,"issuer_cik":"0001351779","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001351779","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":20.1052,"price_display":"20.11","price_state":"stated","total_value":4423144.0,"total_display":"4,423,144.00","total_whole":"4,423,144","shares_owned_after":738209.0,"shares_owned_after_display":"738,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-12-07","scope":"insider"},{"id":5057699,"accession":"0001213900-21-041711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-041711","line_url":"/filing/0001213900-21-041711#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":20.1052,"price_display":"20.11","price_state":"stated","total_value":4423144.0,"total_display":"4,423,144.00","total_whole":"4,423,144","shares_owned_after":648573.0,"shares_owned_after_display":"648,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider"},{"id":6589318,"accession":"0001213900-18-009128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-009128","line_url":"/filing/0001213900-18-009128#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":122.0,"shares_display":"122","price_per_share":5.9195,"price_display":"5.92","price_state":"stated","total_value":722.179,"total_display":"722.18","total_whole":"722","shares_owned_after":958209.0,"shares_owned_after_display":"958,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-11","filed_date":"2018-07-12","scope":"insider"},{"id":6589313,"accession":"0001213900-18-009128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-009128","line_url":"/filing/0001213900-18-009128#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61.0,"shares_display":"61","price_per_share":5.9831,"price_display":"5.98","price_state":"stated","total_value":364.9691,"total_display":"364.97","total_whole":"365","shares_owned_after":958087.0,"shares_owned_after_display":"958,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-12","scope":"insider"},{"id":2480411,"accession":"0001213900-16-013225","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-16-013225","line_url":"/filing/0001213900-16-013225","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.953,"price_display":"6.95","price_state":"stated","total_value":6953.0,"total_display":"6,953.00","total_whole":"6,953","shares_owned_after":958048.0,"shares_owned_after_display":"958,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-12","filed_date":"2016-05-12","scope":"insider","n_lines":4},{"id":8895263,"accession":"0001178913-15-001598","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001178913-15-001598","line_url":"/filing/0001178913-15-001598","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":6.6033333333333335,"price_display":"6.60","price_state":"stated","total_value":3962.0,"total_display":"3,962.00","total_whole":"3,962","shares_owned_after":957048.0,"shares_owned_after_display":"957,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-12","scope":"insider","n_lines":4},{"id":8781995,"accession":"0001178913-15-000942","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001178913-15-000942","line_url":"/filing/0001178913-15-000942","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":3.9325,"price_display":"3.93","price_state":"stated","total_value":6292.0,"total_display":"6,292.00","total_whole":"6,292","shares_owned_after":956448.0,"shares_owned_after_display":"956,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider","n_lines":3},{"id":8781992,"accession":"0001178913-15-000942","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-15-000942","line_url":"/filing/0001178913-15-000942","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001351779","owner_name":"KIDRON NADAV","owner_display_name":"KIDRON NADAV","owner_url":"/insider/0001351779","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":3790.0,"total_display":"3,790.00","total_whole":"3,790","shares_owned_after":954948.0,"shares_owned_after_display":"954,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001176309","name":"ORAMED PHARMACEUTICALS INC.","url":"/issuer/0001176309","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":8,"first_seen":"2015-03-20","last_seen":"2023-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001351779","retrieved_at":"2026-08-24T22:41:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}